|
|
 |
 |
Search Results for: D |
 |
|
 |
|
|
 |
| 16 |
Dorzolamide hydrochloride
Manus Aktteva offers Dorzolamide hydrochloride, 130693-82-2, for your RND, Pilots and commercial requirements with supportive Drug master file
View Detail
| List of Intermediates
|
 |
|
|
| 17 |
Doxazosin Mesylate
Manus Aktteva offers Doxazosin Mesylate,77883-43-3, for your RND, Pilots and commercial requirements with supportive Drug master file. Further, the intermediates also can be made available
View Detail
| List of Intermediates
|
 |
|
|
| 18 |
Dronedarone, Dronedarone Hydrochloride
Manus Aktteva offers Dronedarone, Dronedarone hydrochloride for RND as well as its intermediates for your requirements of evaluation
View Detail
| List of Intermediates
|
 |
|
|
| 19 |
Duloxetine Hydrochloride
Manus Aktteva offers Duloxetine Hydrochloride, 136434-34-9, with DMF, from a WHO GMP plant for your evaluation and commercial requirements.
View Detail
| List of Intermediates
|
 |
|
|
| 20 |
(+)-Di-1,4-toluoyl-D-tartaric acid
Manus Aktteva offers Escitalopram Intermediate, (+)-Di-1,4-toluoyl-D-tartaric acid, anhydrous, 32634-68-7, 99% min, for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 21 |
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
Manus Aktteva offers (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt, 128173-53-5, for your evaluation,pilots and commercial requirements with supportive technical pack....
View Detail
|
 |
|
|
| 22 |
(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)(4-nitrophenyl)methanone
Manus Aktteva offers Conivaptan hydrochloride Intermediate,168626-71-9, (4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)(4-nitrophenyl)methanone, for your evaluation,pilots and commercial requirements with supportive technical package requi....
View Detail
|
 |
|
|
| 23 |
[3-(Dimethylamino)propyl]triphenylphosphonium bromide hydrobromide
Manus Aktteva offers Intermediates of Olopatadine,including[3-(Dimethylamino)propyl] triphenylphosphonium bromide hydrobromide having a cas no 27710-82-3,for your requirements of RND, evaluation, pilots and commercial along with supportive technical ....
View Detail
|
 |
|
|
| 24 |
1,2:5,6-Di-O-isopropylidene-alpha-D-allofuranose
Manus Aktteva offers 1,2:5,6-Di-O-isopropylidene-alpha-D-allofuranose, 2595-05-3, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
| 25 |
1,3-Difluoro-olefinic acid
Manus Aktteva offers 1,3-Difluoro-olefinic acid, Posaconazole intermediate,for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
| 26 |
1,3-Dimethoxybenzene
Manus Aktteva offers 151-10-0, 1,3-Dimethoxybenzene,for your requirements of evaluation, pilots and commercials.
View Detail
|
 |
|
|
| 27 |
1,4-Dioxaspiro[4.5]decan-8-one
Manus Aktteva offers 1,4-Dioxaspiro[4.5]decan-8-one,4746-97-8,for your requirements of evaluation, pilots and commercials.
View Detail
|
 |
|
|
| 28 |
1,6-Dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(phenylmethoxy)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxylic acid methyl ester
Manus Aktteva offers Raltegravir Intermediate,888504-27-6, 1,6-Dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(phenylmethoxy) carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxylic acid methyl ester,for your evaluation,pilots and commercial requirements with....
View Detail
|
 |
|
|
| 29 |
1-(2,3-Dichlorophenyl)piperazine hydrochloride
Manus Aktteva offers 119532-26-2, one of the Intermediates of Aripiprazole, 1-(2,3-Dichlorophenyl)piperazine hydrochloride, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluatio....
View Detail
|
 |
|
|
| 30 |
1-(4,5-Diamino-10-aza-tricyclo[6.3.1.0]dodeca-2,4,6-trien-10-yl)-2,2,2-trifluoro-ethanone
Manus Aktteva offers Varenicline intermediate, 1-(4,5-Diamino-10-aza-tricyclo[6.3.1.0]dodeca-
2,4,6-trien-10-yl)-2,2,2-trifluoro-ethanone, 230615-69-7, for your evaluation, pilots and commercial requirements with supportive technical package require....
View Detail
|
 |
|
|
|
|
|
|
|
 |
NOTE:
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|